Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...
This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest ...
Recently published Neuromyelitis Optica Spectrum Disorder Market Insights report includes a comprehensive understanding of ...
CTNS-RD-04, an ex vivo gene therapy for cystinosis, showed reduced white-cell cystine levels and an acceptable safety profile ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...
After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...
The neuromyelitis optica spectrum disorder market size in the 7MM is expected to show positive growth during the forecast period (2026-2036), mainly attributed to the increasing prevalence of ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.
Postdoctoral researcher Mofizur Rahman from the University of Kansas discusses his work, which focuses on engineering ...
Climate Compass on MSN
The desalination mirage: Why turning the ocean into drinking water is harder than we thought
For decades, desalination has been pitched as the ultimate solution to water scarcity. With oceans covering more than seventy ...
Complementary biochemical and structural findings reveal molecular principles underlying substrate selectivity by a model hyaluronan synthase.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results